Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bleyer

Showing results (571-580 of 664) with videos related to

Pageof 67
Sort By:
Scientific Reports|October 5, 2021
A T cell-intrinsic function for NF-κB RelB in experimental autoimmune encephalomyelitisGuilhem Lalle, Raphaëlle Lautraite, Allison Voisin, et al.
Journal of the National Cancer Institute|May 28, 2010
Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trialCharles Lu, J Jack Lee, Ritsuko Komaki, et al.
Blood|November 10, 1998
Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch studyF M Balis, J S Holcenberg, D G Poplack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer GroupP G Steinherz, P S Gaynon, J C Breneman, et al.
Oral Oncology|March 18, 2025
Oral HPV incidence and risk factors for acquisitionGypsyamber DSouza, Sakshi Tewari, Tanya Troy, et al.
Leukemia & Lymphoma|December 16, 2006
Very high-dose methotrexate (33.6 g/m(2)) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144PPaul C Nathan, Trish Whitcomb, Pamela L Wolters, et al.
Plos One|September 7, 2012
LPS-induced lung inflammation in marmoset monkeys - an acute model for anti-inflammatory drug testingSophie Seehase, Hans-Dieter Lauenstein, Christina Schlumbohm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2024
Xevinapant Combined with Pembrolizumab in Patients with Advanced, Pretreated, Colorectal and Pancreatic Cancer: Results of the Phase Ib/II CATRIPCA TrialAllison Voisin, Catherine Terret, Camille Schiffler, et al.
Cell Death & Disease|December 23, 2025
Simultaneous targeting of KRAS and CDK4 synergistically induces durable growth arrest in pancreatic cancer cellsMaj-Britt Paulsohn, Klara Henrike Frahnert, Denise Schlösser, et al.
Kidney International Reports|May 14, 2023
Bi-allelic <i>REN</i> Mutations and Undetectable Plasma Renin Activity in a Patient With Progressive CKDSofia Jorge, Kendrah Kidd, Petr Vylet'al, et al.
Pageof 67

Showing results (571-580 of 664) with videos related to

Sort By:
Pageof 67
Scientific Reports|October 5, 2021
A T cell-intrinsic function for NF-κB RelB in experimental autoimmune encephalomyelitisGuilhem Lalle, Raphaëlle Lautraite, Allison Voisin, et al.
Journal of the National Cancer Institute|May 28, 2010
Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trialCharles Lu, J Jack Lee, Ritsuko Komaki, et al.
Blood|November 10, 1998
Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch studyF M Balis, J S Holcenberg, D G Poplack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer GroupP G Steinherz, P S Gaynon, J C Breneman, et al.
Oral Oncology|March 18, 2025
Oral HPV incidence and risk factors for acquisitionGypsyamber DSouza, Sakshi Tewari, Tanya Troy, et al.
Leukemia & Lymphoma|December 16, 2006
Very high-dose methotrexate (33.6 g/m(2)) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144PPaul C Nathan, Trish Whitcomb, Pamela L Wolters, et al.
Plos One|September 7, 2012
LPS-induced lung inflammation in marmoset monkeys - an acute model for anti-inflammatory drug testingSophie Seehase, Hans-Dieter Lauenstein, Christina Schlumbohm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2024
Xevinapant Combined with Pembrolizumab in Patients with Advanced, Pretreated, Colorectal and Pancreatic Cancer: Results of the Phase Ib/II CATRIPCA TrialAllison Voisin, Catherine Terret, Camille Schiffler, et al.
Cell Death & Disease|December 23, 2025
Simultaneous targeting of KRAS and CDK4 synergistically induces durable growth arrest in pancreatic cancer cellsMaj-Britt Paulsohn, Klara Henrike Frahnert, Denise Schlösser, et al.
Kidney International Reports|May 14, 2023
Bi-allelic <i>REN</i> Mutations and Undetectable Plasma Renin Activity in a Patient With Progressive CKDSofia Jorge, Kendrah Kidd, Petr Vylet'al, et al.
Pageof 67